Regulatory Updates
Sep 24, 2026•1 min read
Relay Protest Marks 359th Day Demanding Reform of Korean Herbal Pharmacist Licensing
A relay protest in front of Seoul’s Blue House entered its 359th day, with officials urging the government and parliament to clarify and reform the licensing system for pharmacists and herbal pharmacists.
Regulatory Updates
Sep 23, 2026•1 min read
GC Green Cross Advances mRNA COVID-19 Vaccine GC4006A to Phase 2 Trial
GC Green Cross secured MFDS IND approval for its mRNA COVID‑19 vaccine candidate GC4006A and will begin a Phase 2 study in Korea targeting adults 19‑85, aiming for domestic self‑sufficiency by 2028.
Regulatory Updates
Sep 23, 2026•1 min read
Pharmacists' Association Holds 357th Day Relay Protest Demanding Regulatory Reform for Han‑yak Pharmacists
The Korean Pharmacists' Association staged its 357th consecutive relay protest in front of the Blue House, urging the government and National Assembly to clarify licensing scopes and resolve role conflicts between pharmacists and han‑yak (traditional medicine) pharmacists.
Regulatory Updates
Sep 23, 2026•1 min read
Seongdong-gu Pharmaceutical Association Commits to Oppose Expansion of Drug Delivery and Convenience Store Sales
The Seongdong-gu Pharmaceutical Association resolved to actively oppose the expansion of drug delivery services and convenience‑store drug sales, sharing recent pharmacy complaint cases.
Regulatory Updates
Sep 23, 2026•1 min read
Korean Health & Welfare Committee Tensions Over MFDS Role Amid Minister Nominee Scrutiny
The first regular Health and Welfare Committee meeting showed sharp partisan clashes, focusing on the MFDS’s responsibility linked to the Justice Minister nominee.
1
Regulatory Updates
Sep 22, 2026•1 min read
Korean Parliament Begins Review of ‘Pharmacy External Capital Prevention Law’ to curb warehouse‑type pharmacies
Following earlier network‑pharmacy and name‑restriction laws, a new bill targeting external capital in pharmacies entered discussion, aiming to limit operators to one outlet and ban terms like “warehouse.”
Regulatory Updates
Sep 22, 2026•1 min read
Lee Yoon-hak, New Head of Drug Price Negotiations, Prioritizes Essential Medicine Access and Innovation
Lee Yoon-hak, appointed head of drug price negotiations at Korea’s Health Insurance Review & Assessment Service, vows to boost essential medicine access, foster new‑drug development and ensure rational post‑pricing management.
Regulatory Updates
Sep 22, 2026•1 min read
MFDS Revises Standard Decoction Definition, Holds Briefing for Herbal Medicine Manufacturers
The Korean MFDS announced a meeting on Oct 10 to guide herbal medicine makers on the new standard decoction definition effective Sep 2024 and share change‑approval procedures.
Regulatory Updates
Sep 22, 2026•1 min read
MFDS Revises Digital Therapeutic Device Clinical Trial Guidelines for 7 Indications
South Korea's MFDS has detailed new review criteria and updated guidelines for digital therapeutic device trials covering seven mental‑health and substance‑use disorders.
Regulatory Updates
Sep 22, 2026•1 min read
Lawmaker Calls for Removal of Health‑Insurance Limits on Infertility Treatment in Korea
A Korean lawmaker urged the government to lift caps on IVF and IUI coverage under national health insurance, citing patient cost barriers and the need for case‑by‑case care.
Regulatory Updates
Sep 22, 2026•1 min read
Korean medical groups call for stricter GLP‑1 obesity drug prescription controls
Rising GLP‑1 obesity drug prescriptions in Korea prompt calls for enhanced misuse prevention and clinical appropriateness checks.
Regulatory Updates
Sep 22, 2026•1 min read
Korean Pharmacy Association Calls for Public Telemedicine Platform
The Korean Pharmacy Association for Health Society urges a shift to a public, non‑profit telemedicine platform ahead of the December 24 medical law amendment.